|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|
| Property, plant and equipment | ||||||||
| Intangible assets | ||||||||
| Biological assets | ||||||||
| Investments in associates | ||||||||
| Inventories | ||||||||
| Other non-financial assets | ||||||||
| Trade and other receivables | ||||||||
| Other financial assets | ||||||||
| Deferred tax asset | ||||||||
| Total non current assets | ||||||||
| Cash and cash equivalents | ||||||||
| Total current assets | ||||||||
| Total assets | ||||||||
| Capital stock | ||||||||
| Adjustment to capital stock | ||||||||
| Treasury shares | ||||||||
| Adjustment to treasury shares | ||||||||
| Cost of treasury shares | ||||||||
| Legal reserve | ||||||||
| Voluntary reserve | ||||||||
| Other equity accounts | ||||||||
| Voluntary reserve for future dividends distribution | ||||||||
| Retained earnings | ||||||||
| Equity attributable to holders of the parent | ||||||||
| Non-controlling interests | ||||||||
| Total equity | ||||||||
| Non-current liabilities | ||||||||
| Other non-financial liabilities | ||||||||
| Trade and other payables | ||||||||
| Other non-financial liabilities | ||||||||
| Loans and borrowings | ||||||||
| Compensation and employee benefits liabilities | ||||||||
| Provisions | ||||||||
| Income tax payable – Payment plan | ||||||||
| Deferred income tax liabilities | ||||||||
| Total non current liabilities | ||||||||
| Income tax payable | ||||||||
| Total current liabilities | ||||||||
| Total liabilities | ||||||||
| Total equity and liabilities | ||||||||
Loading...
